Repligen | RGEN - المدينين التجاريين





المدينين التجاريين تغيير تاريخ
Agilent USD 1.5B 23M 2026-03
Align Technology USD 1.15B 23.28M 2026-06
Bio Techne USD 214.56M 29.95M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 13.83B 535M 2026-06
Bruker USD 542.7M 2.2M 2026-03
Charles River Laboratories USD 700.25M 727.92M 2026-03
Danaher USD 4.96B 205M 2026-06
Dentsply International USD 622M 66M 2026-03
General Electric Aerospace USD 22.36B 186M 2026-06
Henry Schein USD 1.72B 68M 2026-03
Illumina USD 764M 26M 2026-06
IQVIA Holdings USD 3.39B 12M 2026-06
Mettler Toledo International USD 731.48M 23.27M 2026-06
Myriad Genetics USD 115.3M 2.7M 2025-12
OraSure Technologies USD 22.2M 2.1M 2025-12
Pacific Biosciences Of California USD 35.45M 4.83M 2025-12
Pfizer USD 16.17B 332M 2026-03
Repligen USD 157.71M 6.16M 2026-06
Revvity USD 691.38M 53.29M 2026-03
Standard Biotools USD 41.64M 28.21M 2026-03
Thermo Fisher Scientific USD 9.45B 247M 2026-06
Waters USD 1.76B 930.16M 2026-03
West Pharmaceutical Services USD 712M 26.4M 2026-06